When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Toxic thyroid adenoma

Last reviewed: 23 Jun 2024
Last updated: 17 Jun 2022

Summary

Definition

History and exam

Key diagnostic factors

  • palpable thyroid nodule
  • younger age
Full details

Other diagnostic factors

  • hyperphagia
  • weight loss
  • sweating/heat intolerance
  • nervousness
  • palpitations
  • oligomenorrhea
  • hyperdefecation
  • dyspnea
  • stare or lid lag
  • tachycardia
  • tremor
  • warm moist skin
  • muscle weakness
  • hoarseness
  • dysphagia
  • choking
  • mood change
Full details

Risk factors

  • young adult age
  • iodine deficiency
  • head and neck irradiation
  • family history of thyroid nodules
  • female sex
Full details

Diagnostic tests

1st tests to order

  • thyroid stimulating hormone (TSH)
  • thyroid ultrasound
Full details

Tests to consider

  • free thyroxine (T4; or total T4 with a measure of binding)
  • total T3 with a measure of binding (or free T3)
  • thyroid scan and uptake
  • metabolic panel
  • CBC
  • TSH receptor antibodies
  • thyroid peroxidase antibodies
  • ECG
  • CT neck (noncontrast)
Full details

Treatment algorithm

ONGOING

nonpregnant nonlactating adults without mass effect

nonpregnant nonlactating adults with mass effect

pregnant or lactating

Contributors

Authors

Elizabeth N. Pearce, MD

Professor of Medicine

Boston University Medical Center

Boston

MA

Disclosures

ENP is a member of the Management Council of the Iodine Global Network. She was the 2018-2019 President of the American Thyroid Association (ATA) and served on its board and executive committee until 2020. She is a current member of the ATA's thyroid in pregnancy guidelines writing task force. She is currently a Deputy Editor at the Journal of Clinical Endocrinology and Metabolism and has previously served as an Associated Editor for the journals Thyroid, Endocrine Practice, and Clinical Thyroidology. She is an author of a number of references cited in this topic.

Acknowledgements

Dr Elizabeth N. Pearce would like to gratefully acknowledge Dr Sheila Feit, the previous contributor to this topic.

Peer reviewers

John C. Morris, MD

Professor of Medicine

Mayo Clinic

Rochester

MN

Disclosures

JCM declares that he has no competing interests.

Petros Perros, BSc, MBBS, MD, FRCP

Consultant Endocrinologist

Freeman Hospital

Newcastle-Upon-Tyne

UK

Disclosures

PP declares that he has no competing interests.

  • Toxic thyroid adenoma images
  • Differentials

    • Graves disease
    • Toxic multinodular goiter
    • Thyrotoxic phase of painless lymphocytic thyroiditis
    More Differentials
  • Guidelines

    • Thyroid nodule algorithmic tool white paper
    • Practice parameter for treatment of benign and malignant thyroid disease with I-131 sodium iodide
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer